Assessing Acinetobacter baumannii Virulence and Persistence in a Murine Model of Lung Infection.
Acinetobacter baumannii
Inflammation
Lung infection
Murine model
Pneumonia
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
25
2
2019
pubmed:
25
2
2019
medline:
23
7
2019
Statut:
ppublish
Résumé
Acinetobacter baumannii is a Gram-negative opportunistic pathogen and a leading cause of ventilator-associated pneumonia. Murine models of A. baumannii lung infection allow researchers to experimentally assess A. baumannii virulence and host response. Intranasal administration of A. baumannii models acute lung infection. This chapter describes the methods to test A. baumannii virulence in a murine model of lung infection, including assessing the competitive index of a bacterial mutant and the associated inflammatory responses.
Identifiants
pubmed: 30798564
doi: 10.1007/978-1-4939-9118-1_26
pmc: PMC6446551
mid: NIHMS1016173
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
289-305Subventions
Organisme : NIAID NIH HHS
ID : F32 AI122516
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI101171
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008320
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL094296
Pays : United States
Références
Antimicrob Agents Chemother. 2004 Aug;48(8):3127-9
pubmed: 15273131
Clin Microbiol Infect. 2005 Apr;11(4):319-25
pubmed: 15760430
Am J Respir Crit Care Med. 2006 Jan 1;173(1):122-9
pubmed: 16210672
Clin Infect Dis. 2006 Mar 1;42(5):657-68
pubmed: 16447111
Infect Immun. 2008 Aug;76(8):3577-86
pubmed: 18541654
Clin Microbiol Rev. 2008 Jul;21(3):538-82
pubmed: 18625687
Int J Antimicrob Agents. 2009 Jan;33(1):33-9
pubmed: 18835761
Infect Immun. 2009 Mar;77(3):1015-21
pubmed: 19103777
J Antimicrob Chemother. 2009 May;63(5):982-7
pubmed: 19279050
Antimicrob Agents Chemother. 2009 Jun;53(6):2605-9
pubmed: 19332683
J Antimicrob Chemother. 2009 Oct;64(4):837-9
pubmed: 19696049
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Antimicrob Agents Chemother. 2010 Mar;54(3):1165-72
pubmed: 20047914
Infect Immun. 2010 May;78(5):1952-62
pubmed: 20194595
Infect Immun. 2012 Mar;80(3):1015-24
pubmed: 22232188
CSH Protoc. 2006 Jun 01;2006(1):null
pubmed: 22485253
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14
pubmed: 23221186
Infect Immun. 2013 Feb;81(2):542-51
pubmed: 23230287
PLoS Pathog. 2012;8(12):e1003068
pubmed: 23236280
Proteomics. 2014 Apr;14(7-8):820-828
pubmed: 23754577
Front Cell Infect Microbiol. 2013 Dec 12;3:95
pubmed: 24377089
J Bacteriol. 2014 Jul;196(14):2616-26
pubmed: 24816603
MBio. 2014 Jun 03;5(3):e01163-14
pubmed: 24895306
PLoS Pathog. 2015 Feb 13;11(2):e1004691
pubmed: 25679516
Expert Rev Anti Infect Ther. 2015 May;13(5):567-73
pubmed: 25850806
Infect Immun. 2015 Oct;83(10):4134-41
pubmed: 26238713
MBio. 2015 Nov 10;6(6):e01660-15
pubmed: 26556274
J Bacteriol. 2015 Dec 14;198(4):711-9
pubmed: 26668261
PLoS Pathog. 2016 Jan 14;12(1):e1005391
pubmed: 26764912
Cell Host Microbe. 2016 Jun 8;19(6):826-36
pubmed: 27281572
mSphere. 2015 Nov 04;1(1):null
pubmed: 27303682
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9599-604
pubmed: 27506797
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1288-1301
pubmed: 27573805
MBio. 2016 Sep 27;7(5):null
pubmed: 27677795
J Am Assoc Lab Anim Sci. 2016 Nov;55(6):811-815
pubmed: 27931322
Infect Immun. 2017 Feb 23;85(3):
pubmed: 28052995
J Biol Chem. 2017 Dec 1;292(48):19628-19638
pubmed: 28982978
Sci Rep. 2017 Dec 12;7(1):17429
pubmed: 29234083
Nat Rev Microbiol. 2018 Feb;16(2):91-102
pubmed: 29249812
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Antimicrob Agents Chemother. 1997 Feb;41(2):345-51
pubmed: 9021190